# Selank vs Semax: Comparing the Research on Two Russian Peptides

> Selank vs Semax: two distinct Russian-developed peptides. Selank is a tuftsin-analog anxiolytic; Semax is an ACTH-fragment nootropic. What the research shows about each — cited, never conflated.

A careful comparison that keeps the two compounds distinct — they are not the same molecule and not interchangeable.

## The short version

People constantly pair these two, so a Selank vs Semax page has to start by keeping them apart: they are different peptides with different building blocks and different jobs. Selank is a tuftsin-based heptapeptide studied mainly as an anxiolytic — a calm-the-nerves compound — that works on the brain's GABA system and on the body's own calming peptides. Semax is a different chain derived from a fragment of a stress hormone (ACTH), studied mainly as a nootropic and brain-protectant. Both came out of Russian research, and both are sold as research chemicals and are not FDA-approved. The honest summary: where their effects have been compared in the same animal model, they behave differently, not identically [11]. Below is what the literature actually supports for each, with Selank — this site's subject — cited in detail.

## Two distinct molecules — never conflate them

The single most important point in any Selank vs Semax comparison is that they are not the same compound. Selank is a synthetic analog of tuftsin, the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (TP-7), built by extending tuftsin with a stabilizing C-terminal tail [2]. Semax is a separate synthetic peptide derived from a fragment of the adrenocorticotropic hormone (ACTH) family — a different parent molecule, a different sequence, and a different primary research framing (nootropic and neuroprotective rather than anxiolytic). They share a Russian developmental origin and research-chemical status, but treating them as interchangeable misreads the literature.

## What the research shows for Selank

For Selank, the evidence centers on anxiety-related and immune mechanisms. It acts as a positive allosteric modulator of GABA receptor binding [1], inhibits enkephalin-degrading enzymes in human plasma (IC50 ~15 µM) [2], increases hippocampal BDNF in rats [3], and shifts GABA-pathway gene expression [4]. Russian clinical studies report an anxiolytic effect in generalized anxiety disorder without benzodiazepine-type sedation or dependence [6], alongside immunomodulatory shifts in Th1/Th2 cytokine balance [5]. This is the anxiolytic-and-immunomodulator profile that defines Selank.

## Where the two have been compared directly

The cleanest direct comparison in the cited record is behavioral: in a 6-OHDA-induced Parkinsonian rat model, both Semax and Selank affected behavior, but with distinct profiles [11] — concrete evidence that the two peptides are not pharmacologically equivalent even when tested side by side. This site does not catalog Semax's own mechanism literature in depth (its ACTH-fragment biology is a separate body of work); the responsible takeaway is that each peptide has its own evidence base and its own primary use-case in research, and that the cited Selank findings here should not be transferred onto Semax or vice versa.

## Using them together in research

Some in the research-use community pair the two, reasoning that an anxiolytic and a nootropic address different targets. There is no rigorous controlled human study in mainstream literature establishing the safety or efficacy of a Selank-plus-Semax combination, so any such pairing is anecdotal and unproven. As covered on [Selank effects](/effects), Selank's reach across GABAergic, opioid, monoaminergic, and immune systems makes interaction effects plausible and essentially unstudied — a reason for caution that applies with extra force when stacking a second active peptide. This site makes no recommendation to combine them.

---

A verification-minded reading of the Selank record — the GABA, enkephalinase and monoamine findings logged to source and tagged by evidence strength, the single-region Russian base and unknown human pharmacokinetics named without flinching; no clinic behind the console, and nothing here dispensed or sold.